Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women

被引:110
|
作者
McCrohon, JA
Adams, MR
McCredie, RJ
Robinson, J
Pike, A
Abbey, M
Keech, AC
Celermajer, DS
机构
[1] UNIV SYDNEY, DEPT CARDIOL, ROYAL PRINCE ALFRED HOSP, CAMPERDOWN, NSW 2050, AUSTRALIA
[2] ROYAL PRINCE ALFRED HOSP, DEPT OBSTET & GYNAECOL, CAMPERDOWN, NSW 2050, AUSTRALIA
[3] HEART RES INST, CAMPERDOWN, NSW, AUSTRALIA
[4] CSIRO, DIV HUMAN NUTR, ADELAIDE, SA, AUSTRALIA
[5] UNIV SYDNEY, NATL HLTH & MED RES COUNCIL, CLIN TRIALS CTR, SYDNEY, NSW 2006, AUSTRALIA
关键词
D O I
10.1046/j.1365-2265.1996.8070816.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Oestrogen replacement therapy is associated with a marked reduction in coronary event rates in post-menopausal women. As older age is associated with progressive arterial endothelial damage, a key event in atherosclerosis, we assessed whether hormone replacement therapy (HRT) with oestrogen alone, or oestrogen and progesterone combined, is associated with improved endothelial function in healthy women after the menopause. DESIGN Using high resolution external vascular ultrasound, brachial artery diameter was measured at rest and in response to reactive hyperaemia, with increased flow causing endothelium-dependent dilatation (flow-mediated dilatation). PATIENTS We investigated 135 healthy women; 40 were pre-menopausal (mean +/- SD age/26 +/- 6 years, group 1), 40 were post-menopausal and had never taken HRT (aged 58 +/- 3 years; group 2) and 55 were age-matched postmenopausal women who had taken HRT for greater than or equal to 2 years, from within 2 years of the menopause (aged 57 +/- 4 years; group 3). In group 3, 40 women were on combined oestrogen end progesterone and 15 on oestrogen-only HRT. RESULTS In group 2, flow-mediated dilatation was significantly reduced compared with group 1 (4.4 +/- 3.4 vs 9.6 +/- 3.6%, P < 0.001), consistent with a decline in arterial endothelial function after the menopause. In group 3, however, flow-mediated dilatation was significantly better than group 2 (6.2 +/- 3.3 vs 4.4 +/- 3.4%, P = 0.01), suggesting a protective effect of HRT. Flow-mediated dilatation was similar in women taking oestrogen alone and in those on combined HRT (5.5 +/- 2.8 vs 6.5 +/- 3.4%, P = 0.40). CONCLUSIONS Long-term HRT is associated with improved arterial endothelial function in healthy post-menopausal women. This benefit was observed in both the combined hormone replacement and unopposed oestrogen therapy groups. This may explain some of the apparent cardioprotective effect of HRT after the menopause.
引用
收藏
页码:435 / 441
页数:7
相关论文
共 50 条
  • [31] The effects of hormone replacement therapy on plasma vitamin E levels in post-menopausal women
    Wu, JJ
    Norris, LA
    Wen, YC
    Sheppard, BL
    Feely, J
    Bonnar, J
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1996, 66 (02): : 151 - 154
  • [32] ESTROGEN REPLACEMENT THERAPY DOES NOT AFFECT MUSCLE CFLARACTERISTICS IN HEALTHY POST-MENOPAUSAL WOMEN
    Doyle, J.
    Ng, A. V.
    Sharoff, C.
    Beaudoin, F.
    Kent-Braun, J. A.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2001, 33 (05): : S289 - S289
  • [33] Hormone Replacement Therapy Is Associated with Disease Activity Improvement among Post-Menopausal Women with Inflammatory Bowel Disease
    Freeman, Morgan
    Lally, Lauren
    Teigen, Levi
    Graziano, Elliot
    Shivashankar, Raina
    Shmidt, Eugenia
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [34] Hormone Replacement Therapy Is Associated With Disease Activity Improvement Among Post-Menopausal Women With Inflammatory Bowel Disease
    Lally, Lauren T.
    Freeman, Morgan
    Teigen, Levi
    Shmidt, Eugenia
    Shivashankar, Raina
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S642 - S643
  • [35] Hormone replacement therapy and arterial risk in menopausal women
    Simon, T
    Jaillon, P
    THERAPIE, 2004, 59 (01): : 63 - 70
  • [36] Pre- and post-hormone replacement therapy brain FDG imaging in post-menopausal women
    Verma, RC
    Rahimian, J
    Gan, MP
    Rapkin, AJ
    Chaudhuri, G
    Lemus, J
    RADIOLOGY, 2002, 225 : 465 - 465
  • [37] Hormone replacement therapy and genome-wide DNA methylation among post-menopausal women
    Jordahl, Kristina M.
    Doody, David R.
    Zhang, Yuzheng
    Yan, Donghui
    Randolph, Timothy W.
    Johnson, Lisa G.
    Li, Christopher I.
    Kelsey, Karl
    Houseman, E. Andres
    Wang, Pei
    Malone, Kathleen E.
    Bhatti, Parveen
    CANCER RESEARCH, 2015, 75
  • [38] THE ASSOCIATION BETWEEN HORMONE REPLACEMENT THERAPY AND GASTROPARESIS IN POST-MENOPAUSAL WOMEN: A WORLDWIDE DATABASE ANALYSIS
    Khalil, Jacqueline
    Song, Gengqing
    GASTROENTEROLOGY, 2024, 166 (05) : S1076 - S1076
  • [39] Yield of adenomatous polyps in post-menopausal women undergoing colonoscopy: The role of hormone replacement therapy
    Sorbi, D
    De Luca, L
    Conio, M
    Ott, BJ
    Gostout, CJ
    GASTROINTESTINAL ENDOSCOPY, 1999, 49 (04) : AB68 - AB68
  • [40] The Association between Hormone Replacement Therapy and Gastroparesis in Post-Menopausal Women: A Worldwide Database Analysis
    Khalil, Jacqueline
    Hill, Hannah
    Kaelber, David
    Song, Gengqing
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (03):